Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up
Samantha C Burnham, Christopher C Rowe, David Baker, Ashley I Bush, James D Doecke, Noel G Faux, Simon M Laws, Ralph N Martins, Paul Maruff, S Lance Macaulay, Stephanie Rainey-Smith, Greg Savage, David Ames, Colin L Masters, William Wilson, Victor L Villemagne
Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2016
Core funding for the study was provided by the CSIRO Flagship Collaboration Fund and the Science and Industry Endowment Fund in partnership with Edith Cowan University, Mental Health Research Institute, Alzheimer's Australia, National Ageing Research Institute, Austin Health, Macquarie University, Cogstate Ltd., Hollywood Private Hospital, and Sir Charles Gardner Hospital. The study also receives funding from the National Health and Medical Research Council (NHMRC), the Dementia Collaborative Research Centres program, the McCusker Alzheimer's Research Foundation, and Operational Infrastructure Support from the Government of Victoria. N.G. Faux is supported by a National Health and Medical Research Council training fellowship. S.M. Laws, J.D. Doecke, and W. Wilson receive financial support from the Cooperative Research Centre (CRC) for Mental Health, an Australian Government Initiative. A. I. Bush is supported by the NHMRC, by a program grant, and an Australian Fellowship. V.L. Villemagne is supported by an NHMRC Senior Research Fellowship.